Scorpius is headquartered in San Antonio, Texas, in the heart of a rapidly growing hub for biotechnology and life sciences. With strong investment in science in the region, and a thriving community among biotechs, Scorpius is building on its roots as a team that has developed monoclonal antibodies and fusion protein-based biologics to be a technologically advanced CDMO. Reach out to us today. You’ll get a warm welcome in Texas.
Scorpius BioManufacturing
Latest Content
An Experienced CDMO Can Be a Differentiator in the Rapidly Growing Biologics Market
Paid for and content provided by Scorpius BioManufacturing
The demand for biologic drugs continues to grow at a steady 12–14% annually. To keep up, biotech and biopharma developers are increasingly relying on outsourcing partners to meet both clinical and commercial research, development, and production needs.